For the first time in decades, the U.S. federal government is seriously reconsidering how it classifies cannabis under the Controlled Substances Act. The review follows widespread state-level legalization and public support for reform, signaling a potential turning point in national drug policy.
Currently, cannabis is listed as a Schedule I substance, a category reserved for drugs viewed as having no accepted medical use and a high potential for misuse. This classification, established in 1970, has remained unchanged despite growing evidence of medical benefits and an expanding legal market across many states.
In 2023, the U.S. Department of Health and Human Services (HHS) recommended that cannabis be reclassified to Schedule III, a category that includes substances with accepted medical uses and lower misuse potential. The Drug Enforcement Administration (DEA) is now reviewing that recommendation before issuing a final decision.
Reclassification would not federally legalize cannabis but would represent a major policy shift. It could ease research restrictions, alter federal taxation rules for cannabis businesses, and bring federal standards closer to those of state-regulated markets. However, barriers such as interstate commerce limits and banking restrictions would remain until Congress enacts broader legislation.
The federal review reflects a broader change in public perception. Surveys show that a majority of Americans support medical cannabis access, and many favor further decriminalization or legalization. Policymakers and researchers view this as a sign that national attitudes toward cannabis have evolved significantly since the 1970s.
While the DEA’s review is ongoing, the outcome could have lasting effects on healthcare, scientific study, and the legal cannabis industry. Whatever the result, this marks the most significant federal reconsideration of cannabis
Former White House press secretary Karine Jean-Pierre expressed her thoughts on the “shocking” situation where leaders of the Democratic Party turned against then-President Joe Biden, ultimately pressuring him to withdraw from the race. Now, just over 100 days into President Donald Trump’s second term, the Democratic Party continues to deal with the repercussions of the…
These are the consequences of sleeping with a…See more The Price She Paid When Sleeping with Maria met David at a wedding when she was 25. He was charming, brought her flowers every day, and called her constantly. Her friends said it was too fast, but she thought it was romantic. They married after four…
Mexican President Claudia Sheinbaum criticized the Trump administration’s decision to label eight major drug cartels, including Jalisco New Generation and Sinaloa, as terrorist organizations. She argued that Mexico would not accept U.S. interference in its sovereignty and internal affairs, emphasizing that any collaboration with the U.S. would be based on mutual respect—not subordination. This response…
Eva Schloss, the stepsister of Anne Frank and a woman who stood as one of the final direct witnesses to the atrocities of the Holocaust, died this week at the age of 96. Her passing marks the silencing of a formidable moral voice—one that spent nearly a century navigating the chasm between unimaginable loss and…
When it comes to awards ceremonies, the spotlight often extends far beyond the trophies and speeches, shining brightly on the red carpet and the fashion choices of those attending. In the age of social media, these moments are amplified, sparking real-time discussions and debates over who wore what. This year’s Oscars proved no exception, with…
Reba McEntire is familiar with the pain of sorrow and loss. The country music star was killed in an aeroplane crash in 1991 while performing, along with seven other band members and her tour manager. A private event in San Diego featured a performance by the famous person and her band on March 16, 1991….